Solving a Cash Crunch...

AMC spikes in premarket trading after rasiing $325.5 million. [Trade of the Day Wake-Up Watchlist] Attention Readers: Did you miss it? Yesterday Manward’s Alpesh Patel went rogue and revealed his SHOCKING findings from using artificial intelligence to target big money in the stock market. [Click here to learn how an investing model using ChatGPT could have generated 512% over a 15-month stretch.]( Good Morning Wake-up Watchlisters! While you’re sipping coffee you’ll see stocks rose on Thursday. The latest CPI numbers show inflation cooled slightly. The data came in before the Federal Reserve meets next week to decide if another interest rate hike is needed. More inflation data due today could sway the markets further. The Fed’s rate hike decisions have caused plenty of volatility over the last 18 months, but that doesn’t mean you can’t make winning trades. Over the last three weeks, our Head Trading Tactician Bryan Bottarelli [closed three triple-digit winners]( including a 133% overnight gain on ORCL earlier this week. [Click here learn how overnight trading could double your money in less than 24 hours.]( Here’s a look at the top-moving stocks this morning. AMC Entertainment Holdings (NYSE: AMC) AMC Entertainment is up 8.62% premarket after raising about $325.5 million through the sale of 40 million shares. The company said this move would address a cash crunch as the movie-theater industry looks to bounce back from the pandemic slowdown. The offering, which began Sept. 6, sold stock at an average price of $8.14 a share, the cinema chain said in a statement Wednesday. Citigroup Inc. (NYSE: C) Citigroup is up 0.59% premarket after CEO Jane Fraser announced a new reorganization plan. The company, which currently operates with two divisions, will undergo a transformation into five separate divisions, all directly reporting to the CEO. Fraser says the reorganization will streamline the business and “increase accountability.” [Get in on a Royalty Stream on Dozens of Approved and Upcoming Drugs]( One ticker symbol... A whole portfolio of approved and upcoming treatments. [Click to discover "Healthcare Royalties."]( Alnylam Pharmaceuticals (Nasdaq: ALNY) Alnylam is down 5.74% premarket after its stock was halted on Wednesday as the FDA advisory panel reviews treatment for the Cardiomyopathy of ATTR Amyloidosis. The FDA later backed the expanded use of Alnylam Pharmaceuticals’ gene silencing drug to treat a type of heart disease associated with a rare organ-damaging disorder. Those are the biggest stock movers for today. Happy trading! The Wake-Up Watchlist Research Team [Multimillionaire Investor: "Hands Down the Most Lucrative Discovery of My Entire Career"]( [Account Balance on Phone]( Peabody Award-winning journalist Bill Tucker sat down with a reclusive multimillionaire trader... 858 miles OUTSIDE of Wall Street... to discuss a revolutionary new trading strategy that involves... One ticker... one trade... every week. The fast-hitting profit potential is extraordinary. [Learn More]( [Monument Traders Alliance] Monument Traders Alliance You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist. To unsubscribe from Trade of the Day Wake-Up Watchlist, [click here](. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 [Website]( | [Privacy Policy]( Keep the emails you value from falling into your spam folder. [Whitelist Trade of the Day](. © 2023 Monument Traders Alliance, LLC | All Rights Reserved Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.